Search research articles
Contact Us
Filters
Showing results (51-60 of 72) with videos related to
Page
of 8
Sort By:
Leukemia Research
|
February 26, 2014
Integration of automated morphological features resolves a distinct group of atypical chronic lymphocytic leukemias with chromosomal aberrations
Yair Herishanu, Sigi Kay, Erel Joffe, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 18, 2012
Divergence in CD19-mediated signaling unfolds intraclonal diversity in chronic lymphocytic leukemia, which correlates with disease progression
Yair Herishanu, Sigi Kay, Nili Dezorella, et al.
European Journal of Haematology
|
September 26, 2021
Characteristics and recognition of early infections in patients treated with commercial anti-CD19 CAR-T cells
Ofrat Beyar-Katz, Nino Kikozashvili, Yael Bar On, et al.
American Journal of Hematology
|
June 19, 2019
Characteristics, management and outcome of DLBCL patients, presenting with simultaneous systemic and CNS disease at diagnosis: A retrospective multicenter study
Chava Perry, Sharon Ben Barouch, Neta Goldschmidt, et al.
European Journal of Haematology
|
October 17, 2022
The role of additional chemotherapy prior to autologous HCT in patients with relapse/refractory DLBCL in partial remission-A retrospective multicenter study
Liat Shargian, Odelia Amit, Hanna Bernstine, et al.
Annals of Hematology
|
June 22, 2022
Thrombopoietin receptor agonist for treating bone marrow aplasia following anti-CD19 CAR-T cells-single-center experience
Ofrat Beyar-Katz, Chava Perry, Yael Bar On, et al.
Journal of Personalized Medicine
|
August 27, 2021
Feasibly of CD24/CD11b as a Screening Test for Hematological Malignancies
Shiran Shapira, Dina Kazanov, Fatin Mdah, et al.
Frontiers in Immunology
|
November 16, 2020
Anti-CD20-Mediated B Cell Depletion Is Associated With Bone Preservation in Lymphoma Patients and Bone Mass Increase in Mice
Albert Kolomansky, Irit Kaye, Nathalie Ben-Califa, et al.
Haematologica
|
February 12, 2026
ICANS mitigation in high-risk elderly patients treated with CD28 co-stimulatory anti-CD19 CAR-T cells using a standardization protocol: a pilot study
Gil Fridberg, Odelia Amit, Yehonathan Sherf, et al.
Hematological Oncology
|
November 21, 2024
Ibrutinib With Bendamustine and Rituximab for Treatment of Patients With Relapsed/Refractory Aggressive B-Cell Lymphoma
Meirav Kedmi, Elena Ribakovsy, Ohad Benjamini, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 72) with videos related to
Sort By:
Page
of 8
Leukemia Research
|
February 26, 2014
Integration of automated morphological features resolves a distinct group of atypical chronic lymphocytic leukemias with chromosomal aberrations
Yair Herishanu, Sigi Kay, Erel Joffe, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 18, 2012
Divergence in CD19-mediated signaling unfolds intraclonal diversity in chronic lymphocytic leukemia, which correlates with disease progression
Yair Herishanu, Sigi Kay, Nili Dezorella, et al.
European Journal of Haematology
|
September 26, 2021
Characteristics and recognition of early infections in patients treated with commercial anti-CD19 CAR-T cells
Ofrat Beyar-Katz, Nino Kikozashvili, Yael Bar On, et al.
American Journal of Hematology
|
June 19, 2019
Characteristics, management and outcome of DLBCL patients, presenting with simultaneous systemic and CNS disease at diagnosis: A retrospective multicenter study
Chava Perry, Sharon Ben Barouch, Neta Goldschmidt, et al.
European Journal of Haematology
|
October 17, 2022
The role of additional chemotherapy prior to autologous HCT in patients with relapse/refractory DLBCL in partial remission-A retrospective multicenter study
Liat Shargian, Odelia Amit, Hanna Bernstine, et al.
Annals of Hematology
|
June 22, 2022
Thrombopoietin receptor agonist for treating bone marrow aplasia following anti-CD19 CAR-T cells-single-center experience
Ofrat Beyar-Katz, Chava Perry, Yael Bar On, et al.
Journal of Personalized Medicine
|
August 27, 2021
Feasibly of CD24/CD11b as a Screening Test for Hematological Malignancies
Shiran Shapira, Dina Kazanov, Fatin Mdah, et al.
Frontiers in Immunology
|
November 16, 2020
Anti-CD20-Mediated B Cell Depletion Is Associated With Bone Preservation in Lymphoma Patients and Bone Mass Increase in Mice
Albert Kolomansky, Irit Kaye, Nathalie Ben-Califa, et al.
Haematologica
|
February 12, 2026
ICANS mitigation in high-risk elderly patients treated with CD28 co-stimulatory anti-CD19 CAR-T cells using a standardization protocol: a pilot study
Gil Fridberg, Odelia Amit, Yehonathan Sherf, et al.
Hematological Oncology
|
November 21, 2024
Ibrutinib With Bendamustine and Rituximab for Treatment of Patients With Relapsed/Refractory Aggressive B-Cell Lymphoma
Meirav Kedmi, Elena Ribakovsy, Ohad Benjamini, et al.
Page
of 8